These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1579596)

  • 21. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
    Day RW
    Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood pressure and alpha-vascular reactivity in hypertensive rats treated with amlodipine and dietary Ca.
    Civantos B; Aleixandre A
    Eur J Pharmacol; 2004 Apr; 489(1-2):101-10. PubMed ID: 15063161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepant regulation of QT (QTc) interval duration by calcium channel blockade and angiotensin converting enzyme inhibition in experimental hypertension.
    Klimas J; Vaja V; Vercinska M; Kyselovic J; Krenek P
    Basic Clin Pharmacol Toxicol; 2012 Oct; 111(4):279-88. PubMed ID: 22626243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a new 1,4-dihydropyridine, lacidipine, on gastrointestinal motility and other gastrointestinal functions.
    Toson G; Ceserani R; Corsi M; Bettelini L; De Ponti F; D'Angelo L; Crema A
    Pharmacology; 1990; 41(5):246-55. PubMed ID: 2092328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence that lacidipine at nonsustained antihypertensive doses activates nitrogen monoxide system in the endothelium of salt-loaded Dahl-S rats.
    Crespi F; Vecchiato E; Lazzarini C; Andreoli M; Gaviraghi G
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):471-7. PubMed ID: 11904520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade.
    Noll G; Lüscher TF
    Cardiology; 1998; 89 Suppl 1():10-5. PubMed ID: 9570424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium blocker lacidipine and carotid arteriolar vasodilation in healthy volunteers.
    Safar M; Bons J; Georges D; Cournot A; Duchier J
    Clin Pharmacol Ther; 1989 Jul; 46(1):94-8. PubMed ID: 2663319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology of lacidipine.
    Hall ST; Harding SM; Evans GL; Pellegatti M; Rizzini P
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S9-13. PubMed ID: 1726014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of the effects of lacidipine and enalapril on the left ventricular cardiomyocyte remodeling in spontaneously hypertensive rats.
    Cagalinec M; Kyselovic J; Blaskova E; Bacharova L; Chorvat D; Chorvatova A
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):561-70. PubMed ID: 16680070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic profile of Ro 40-5967 in conscious rats: comparison with diltiazem, verapamil, and amlodipine.
    Véniant M; Clozel JP; Hess P; Wolfgang R
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S55-8. PubMed ID: 1725005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacological properties of lipophilic calcium antagonists.
    van Zwieten PA
    Blood Press Suppl; 1998; 2():5-9. PubMed ID: 9850436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology of the dihydropyridine calcium antagonists: relationship between lipophilicity and pharmacodynamic responses.
    van Zwieten PA; Pfaffendorf M
    J Hypertens Suppl; 1993 Dec; 11(6):S3-8. PubMed ID: 8169379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine.
    Trazzi S; Santucciu C; Mancia G
    J Hypertens Suppl; 1993 Dec; 11(6):S17-20. PubMed ID: 8169377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of four calcium channel blockers on central cardiovascular control.
    Montastruc JL; Damase-Michel C; Dang-Tran L; Montastruc P
    Arch Int Pharmacodyn Ther; 1989; 297():112-9. PubMed ID: 2730230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
    Pruneau D; Roy F; Brown NL
    Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacodynamics of nilvadipine, a new dihydropyridine-type calcium antagonist.
    Honerjäger P; Seibel K
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S15-21. PubMed ID: 1283184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of the cardiac and vasodilatory effects of some calcium entry blockers in perfused isolated guinea-pig hearts.
    Boddeke HW; Wilffert B; Heynis JB; van de Haar Keuken V; Jonkman FA; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1987 Aug; 288(2):175-85. PubMed ID: 3675080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.